Review of Burn Resuscitation: Is Plasmalyte® a Comparable Alternative to Ringer's Lactate?


Journal

Journal of burn care & research : official publication of the American Burn Association
ISSN: 1559-0488
Titre abrégé: J Burn Care Res
Pays: England
ID NLM: 101262774

Informations de publication

Date de publication:
05 01 2023
Historique:
pubmed: 3 8 2022
medline: 11 1 2023
entrez: 2 8 2022
Statut: ppublish

Résumé

Ringer's lactate has been the most widely used fluid for burn resuscitation for decades. Plasmalyte® (PL), a newer balanced crystalloid, is gaining popularity for use in the critically ill, including patients with burns. This popularity is partly due to the fact that PL theoretically offers a favorable metabolic profile, but may also be attributed to its relatively lower cost. Patients who are critically ill with large burns receive enormous volumes of fluids, especially during the resuscitation period. The choice of balanced crystalloid solution used is likely to have an impact on the metabolic status of patients and their overall outcomes. The choice of fluid for burn resuscitation has been one of the most researched topics in burn care and various types of fluids have been superseded based on research findings. This narrative review examines the evidence guiding fluid management in burns and explores the data supporting the use of balanced crystalloid solutions, in particular PL for burn resuscitation. Our literature search revealed only one study that focused on a direct comparison between PL and standard Ringer's Lactate for burn resuscitation. Based on the limited literature on the use of PL in burns, it is difficult to draw meaningful conclusions. Further research, into the suitability of PL for use in burns, is needed before formulary changes are instituted widely.

Identifiants

pubmed: 35917832
pii: 6653512
doi: 10.1093/jbcr/irac106
doi:

Substances chimiques

Ringer's Lactate 0
Crystalloid Solutions 0
Plasmalyte R 97397-06-3
Isotonic Solutions 0

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

81-86

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the American Burn Association. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Laura Cappuyns (L)

Whiston Hospital, Prescot, Merseyside, UK.
Centre for Bioscience, Manchester Metropolitan University, Manchester, UK.

Ascanio Tridente (A)

Whiston Hospital, Prescot, Merseyside, UK.

Yvonne Stubbington (Y)

Whiston Hospital, Prescot, Merseyside, UK.

Nina Claire Dempsey-Hibbert (NC)

Centre for Bioscience, Manchester Metropolitan University, Manchester, UK.

Kayvan Shokrollahi (K)

Whiston Hospital, Prescot, Merseyside, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH